summary

UCLA Health - What Are My Treatment Options for the Small Renal Mass | UCLA Health | Brian Shuch, MD

Thumbnail of the video “UCLA Health - What Are My Treatment Options for the Small Renal Mass | UCLA Health | Brian Shuch, MD”
Community upload. AI output has not been independently verified.

Short Summary

Main recommendation: Choose a small renal mass treatment based on the tumor's type, location, grade, and size, the patient's health and preferences, and whether more information (biopsy or advanced imaging) would change the decision; active surveillance is a reasonable option for most small tumors, while partial nephrectomy, radical nephrectomy, or needle ablation are alternatives depending on the case. Dr. Brian Shuch notes there are no randomized trials comparing these therapies, so the choice often comes down to patient preference along with diagnostic and management considerations.

Key Points

  • Tumor risk is described with the video's analogy: a "guppy" is benign or indolent, a "goldfish" is low-aggressive, and a "shark" is aggressive, with the speaker saying most tumors under four centimeters fall into the low-aggressive group.
  • Active surveillance is the approach of watching the tumor; the speaker says most grow slowly (zero to four millimeters per year), and cure remains possible over 99 percent of the time, though some patients find it hard to tolerate observation.
  • Partial nephrectomy removes only the tumor, sparing most of the kidney, with local recurrence the speaker says is usually about two to eight percent, typically requiring general anesthesia and a short overnight hospital stay.
  • Radical nephrectomy, removal of the whole kidney, is usually reserved for tumors around four centimeters when the kidney is not working or the tumor is in a difficult location, or when the patient prefers to avoid the risk of a challenging partial procedure.
  • Needle ablation (cryoablation, radiofrequency, or microwave) is suited to small tumors in accessible locations, often the back of the kidney, with success the speaker describes as about 70 to 95 percent depending on size and location.

Details Worth Noting

  • Concrete instructions: Before deciding, ask yourself whether more information would help; if yes, ask about a biopsy or advanced nuclear medicine imaging. If you prefer to decide without more information, consider whether you would regret not knowing later (for example, learning the tumor was benign after surgery).
  • Concrete instructions: Make sure your team discusses all options, and consider a second opinion if you are uncertain; the speaker says a second opinion often adds clarity.
  • Concrete instructions: Clarify your priorities (speed of recovery versus complete tumor removal) and choose a doctor who can care for you over the long term, since follow-up is ongoing.
  • Ablation success is lower for larger tumors (about 75 percent in the speaker's example); if it fails, another needle ablation can often be done.
  • Non-invasive options such as stereotactic radiation or externally applied high-intensity focused ultrasound are described as emerging future possibilities, not current standards.
  • The speaker notes that about 22 kidney cancer types exist, and tumor location (deeper or near critical structures) can make treatment more challenging.

Bottom Line

Small renal mass management is a personal decision with several valid paths, so understanding your tumor's characteristics, your priorities, and whether more information would change your choice matters more than a single standard answer.